Eyeworld

EW CATARACT 35 July 2018 present research on miLOOP at the ASCRS•ASOA Annual Meeting, said he has been using miLOOP for more than a year and is figuring out what cases to use it on—the majority of cases, including routine, or just more complicated situations. "I can make an argument for ei- ther strategy, and we've been doing an evaluation to see if we should use it on every case," he said. At the very least, Dr. Wiley said he sees val- ue in using it in cases of small pu- pils, thicker or dense cataracts that the femtosecond laser can't soften, cases where the patient might not be able to afford to upgrade but would benefit from decreased use of phaco energy, and as a rescue tool in chop cases where the first crack proves difficult. He has done research (not yet published) that found use of mi- LOOP to prechop the lens reduces the amount of time the phaco hand- piece is in the eye and that the I/A tip is in the eye by 20% and 30%, respectively. "miLOOP takes 20–30 seconds to bisect the nucleus, but you gain a lot of that back by having less phaco and less I/A in the eye, overall de- creasing the risk of complications," Dr. Wiley said. Dr. MacDonald said she looks forward to larger studies involving miLOOP that evaluate its effect on efficiency in the OR, case times, and surgical times, as well as endothelial cell counts compared to traditional cataract surgery. In the future, Dr. Wiley thinks miLOOP will be a tool that some surgeons find indispensable in certain situations. Just like some surgeons find iris expansion rings a must-have in certain situations, so too Dr. Wiley said they'll consider miLOOP. "I think there will be cases where almost every surgeon will have the opportunity to benefit from it," Dr. Wiley said. EW Reference 1. Ianchulev T, et al. Microinterventional endocapsular nucleus disassembly: novel technique and results of first-in-human randomized controlled study. Br J Ophthalmol. 2018 Apr. Epub ahead of print. Editors' note: The physicians have financial interests with Iantech. Contact information Ianchulev: tianchul@privatemedicalequity.com MacDonald: susanmacdonaldeyecorps@gmail.com Wiley: wiley@cle2020.com I-Ring ® Pupil Expander BVI, BVI Logo and all other trademarks (unless noted otherwise) are property of Beaver-Visitec International ("BVI") © 2018 BVI Beaver-Visitec International, Inc. US: 1-866-906-8080 EU: 44 (0) 1865 601256 bvimedical.com A safe and effective solution for intraoperative small pupil expansion • Gentle on iris and other intraocular tissue • Iris quickly returns to natural shape post-surgery • One step, back fl ip removal process • Easy insertion Call your local sales rep or customer service at 1-866-906-8080 Visit iring.net for clinical information For information on all BVI products, visit bvimedical.com Iris quickly returns to natural shape post-surgery "I particularly like the I-Ring because I fi nd it does not distort the pupil or tear the sphincter." — Eric Donnenfeld, MD

• Blank Page
• Blank Page (1)